Información del producto
- Ammonium, diethyl(2-hydroxyethyl)methyl-, 3-methyl-2-phenylvalerate (ester)
- Ethanaminium, N,N-diethyl-N-methyl-2-[(3-methyl-1-oxo-2-phenylpentyl)oxy]-
- Ethanaminium, N,N-diethyl-N-methyl-2-[(3-methyl-1-oxo-2-phenylpentyl)oxy]- (9CI)
- N,N-Diethyl-N-methyl-2-[(3-methyl-1-oxo-2-phenylpentyl)oxy]ethanaminium
Valethamate is a pharmaceutical drug that is administered to women for the treatment of urinary incontinence. It is used in combination with pentobarbital sodium and other drugs, such as fatty acids and depressants, to treat urinary incontinence. Valethamate inhibits spontaneous activity in the detrusor muscle by blocking the action of norepinephrine on alpha-adrenergic receptors. This drug has been shown to be clinically effective for treating urinary incontinence in women who have not responded to other treatments. Valethamate has also been shown to cause vessel occlusion when injected into the femoral vein of experimental animals and may increase blood pressure when given intravenously.
Propiedades químicas
Consulta técnica sobre: 3D-FH171076 Valethamate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
